Remicade (infliximab) is a biologic DMARD medication produced by Janssen Pharmaceuticals. It is used in Ghana to treat inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis. Administered intravenously, Remicade targets and neutralizes the protein TNF-alpha to reduce inflammation. Its use requires medical supervision and may have side effects. For personalized information and guidance, consulting a healthcare professional and referring to the official documentation is recommended.

Our team was responsible for the localized design of patient information booklets, patient cards, administrative reconstructive guides, and Rapidly Connect patient booklets. Pull-up banners were also designed and printed to effectively highlight the benefits and relief Remicade provides during presentations and medical forums.